Alnylam Pharmaceuticals
ALNY
#1109
Rank
ยฃ16.12 B
Marketcap
ยฃ120.41
Share price
5.41%
Change (1 day)
-64.96%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company